8 February, Workshop, Maryland, USA
The USA Food and Drug Administration (FDA) is running a public workshop to have a scientific discussion of the current methods available for identifying and characterising infectious disease risks associated with human cells, tissues, and cellular and tissue-based products (HCT/Ps).
For more details email Monica Kapoor or Stacey Rivette at the Center for Biologics Evaluation and Research, FDA CBERPublicEvents@fda.hhs.gov with the subject line titled “HCT/P Workshop.”
Organiser: FDA
http://www.fda.gov/BiologicsBloodVaccines/NewsEvents/WorkshopsMeetingsConferences/ucm525001.htm
